Beyond The Pap Smear Test: Enhanced Screening Of Cervical Cancer In Women ≥30 – Mainpro+
$0
free
Mainpro+
Women's Health, Oncology
1 Credits
Course Description
Course Details
Expiry Date: 2019-03-06
Professions: Physician
Faculty
Mona Kamel (MD, BCh, FRCPC), Pravinsagar Mehta (MD, CCFP, FCFP), Jeff Habert (MD, CCFP, FCFP), Daniel Ngui (BSc, PT, MD, FCFP)
Accreditation
Learning Objective(s)
Upon completion of this program, participants will be able to:
- Identify the characteristics and predictors of cervical cancer.
- Identify available screening tests, including cytology testing (Pap smear test), liquid-based cytology testing (LBC), and Cotesting (Pap/HPV).
- Identify the importance of screening and HPV testing for cervical cancer in women ≥30 years of age at high-risk for the HPV (Human Papillomavirus).
- Acknowledge current guidelines regarding HPV testing for cervical cancer in women ≥30 years of age.
- Recommend HPV tests to triage women ≥30 years of age for cervical cancer.